Monthly Archives: February 2019
Hypertrophic scarring: the rabbit ear model for studying dermal fibrosis
Compounded medication for patients with rare diseases
Pharmaceutical compounding is the preparation of unlicensed medicines in order to meet specific patient needs that do not have a licensed (commercial) medicine available on the market. Especially for patients with rare diseases it is complementary when
The importance of immature cancer cells in predicting patient outcome
Surgical strategies to preserve the right heart function during tetralogy of Fallot repair
Negative regulators of cell death signalling pathways in cancer
Training the immune system to treat Niemann-Pick type C1 disease
Do you want a specific signal? Go local! Imaging our way to targeted therapy
Cyclic adenosine monophosphate (cAMP) is a ubiquitous intracellular second messenger, a small molecule that conveys the information carried by hormones, neurotransmitters and other extracellular stimuli to the intracellular environment. cAMP is generated at the plasma membrane when